Comparing the use of radiolabeled SSTR agonists and an SSTR antagonist in breast cancer: does the model choice influence the outcome?
Crossref DOI link: https://doi.org/10.1186/s41181-017-0030-z
Published Online: 2017-09-29
Published Print: 2017-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Dalm, Simone U.
de Jong, Marion
License valid from 2017-09-29